ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Pneumocystis jirovecii pneumonia | 22.07.08.009; 11.03.07.005 | 0.000576% | | Not Available |
Medication residue present | 13.15.01.032 | - | - | Not Available |
Candida infection | 11.03.03.021 | - | - | |
Multiple organ dysfunction syndrome | 08.01.03.057 | - | - | |
Anal incontinence | 17.05.01.021; 07.01.06.029 | - | - | |
Liver function test increased | 13.03.01.044 | 0.014710% | | Not Available |
Blood aldosterone increased | 13.10.09.009 | 0.001471% | | Not Available |
Cholangitis acute | 09.02.01.006 | 0.001471% | | Not Available |
Cystitis radiation | 20.03.02.009; 12.05.02.009 | 0.001471% | | Not Available |
Full blood count decreased | 13.01.07.004 | - | - | Not Available |
Metastases to bone | 16.22.02.005; 15.09.03.006 | 0.015445% | | Not Available |
Metastases to lymph nodes | 16.22.02.006; 01.09.01.015 | 0.000576% | | Not Available |
Obstructive uropathy | 20.01.05.004 | 0.002206% | | Not Available |
Penile size reduced | 21.12.01.018 | 0.001471% | | Not Available |
Pernicious anaemia | 10.04.01.007; 07.17.01.004; 01.03.01.003 | 0.001471% | | Not Available |
Prostate cancer recurrent | 21.04.02.008; 16.25.01.005 | 0.000576% | | Not Available |
Prostate cancer stage IV | 21.04.02.010; 16.25.01.007 | 0.000576% | | Not Available |
Prostatic specific antigen decreased | 13.22.01.002 | 0.003677% | | Not Available |
Urinary bladder haemorrhage | 24.07.01.086; 20.03.01.023 | 0.001471% | | Not Available |
Terminal state | 08.01.03.079 | 0.000384% | | Not Available |
Metastases to bone marrow | 16.22.02.013; 01.05.01.022 | 0.002942% | | Not Available |
Metastases to meninges | 17.02.10.012; 16.22.02.003 | 0.000384% | | Not Available |
Pulmonary sepsis | 22.07.01.014; 11.01.11.014 | 0.000384% | | Not Available |
Meningorrhagia | 17.08.01.056; 12.01.10.016; 24.07.04.030 | 0.000576% | | Not Available |
Lymphangiosis carcinomatosa | 24.09.02.007; 16.22.02.009; 01.09.01.027 | 0.000576% | | Not Available |
Clostridium difficile infection | 11.02.02.009 | - | - | Not Available |
Prostatic specific antigen abnormal | 13.22.01.015 | 0.007355% | | Not Available |
Pancreatic carcinoma stage IV | 16.13.10.005; 07.21.09.008 | 0.000384% | | Not Available |
Communication disorder | 19.19.01.008 | 0.001471% | | Not Available |
Sarcopenia | 15.05.06.004 | 0.000384% | | Not Available |